The MarketWatch News Department was not involved in the creation of this content. -- Companion Spine is the first company in the world with a product portfolio solely focused on Total Disease State ...

Strategic step to strengthen Companion Spine’s global leadership in posterior dynamic spine stabilization and spine motion preservation. The combined product portfolio will reinforce Companion Spine’s ...

Paradigm Spine has announced it has received FDA approval for its interlaminar technology, according to a news release (pdf). Coflex is a minimally invasive, motion preserving interlaminar ...

Performance in Q4 was impacted by the early closing of the Companion Spine deal, which removed approximately $2 million of ...

Please provide your email address to receive an email when new articles are posted on . Proprio received FDA 510(k) clearance of its Paradigm spine surgery navigation ...

Paradigm Spine made four new appointments to its leadership team. Here’s what you should know. 1. The company named Francis Magee, DVM, its chief technology officer; Charlie Gilbride its executive ...

Surgical implant company RTI Surgical Inc. will buy motion preservation-focused spinal implant player Paradigm Spine LLC for up to $300 million in cash and stock. The Alachua, Fla.-based small-cap ...

Paradigm Spine LLC, a venture-backed provider of spinal implant technologies, has received up to $75 million in secured debt financing from PDL BioPharma Inc., a publicly traded company that manages ...

Companion Spine is the first company in the world with a product portfolio solely focused on Total Disease State Solutions™ (“TDS™”) for degenerative spine diseases. This acquisition creates the world ...

Companion Spine LLC (“Companion Spine” or “the Company”), the French-American specialist in spine implant surgery, announced today that it has completed its previously announced acquisition of the ...